[HTML][HTML] Immunogenicity of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine compared to …
T John, M Voysey, LM Yu, N McCarthy, M Baudin… - Vaccine, 2015 - Elsevier
This serological follow up study assessed the kinetics of antibody response in children who
previously participated in a single centre, open-label, randomised controlled trial of low …
previously participated in a single centre, open-label, randomised controlled trial of low …
Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after …
M Kovac, L Kostanyan, N Mesaros… - Human Vaccines & …, 2018 - Taylor & Francis
Pertussis is a highly contagious disease, for which periodic peaks in incidence and an
increasing number of outbreaks have been observed over the last decades. The reduced …
increasing number of outbreaks have been observed over the last decades. The reduced …
Randomized, Controlled, Multicenter Study of the Immunogenicity and Safety of a Fully Liquid Combination Diphtheria–Tetanus Toxoid–Five-Component Acellular …
T Vesikari, SA Silfverdal, F Boisnard… - Clinical and Vaccine …, 2013 - Am Soc Microbiol
This study compared the levels of immunogenicity and safety of diphtheria–tetanus toxoid–
five-component acellular pertussis (DTaP5), inactivated poliovirus (IPV), and Haemophilus …
five-component acellular pertussis (DTaP5), inactivated poliovirus (IPV), and Haemophilus …
[HTML][HTML] Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria …
D Brandon, M Kimmel, SO Kuriyakose, L Kostanyan… - Vaccine, 2018 - Elsevier
Background Over the last decades, pertussis showed periodic increases in its incidence
among adults, despite being a vaccine-preventable disease. Methods This phase III …
among adults, despite being a vaccine-preventable disease. Methods This phase III …
Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-inactivated polio vaccine-Haemophilus influenzae type b vaccine administered at 2-4 …
RM Carlsson, BA Claesson, U Selstam… - The Pediatric …, 1998 - journals.lww.com
Methods. In an open randomized study we compared the safety and immunogenicity of two
schedules for priming and booster vaccinations of infants. A pentavalent combination …
schedules for priming and booster vaccinations of infants. A pentavalent combination …
[HTML][HTML] The effectiveness and safety of pertussis booster vaccination for adolescents and adults: A systematic review and meta-analysis
J Xu, S Liu, Q Liu, R Rong, W Tang, Q Wang, S Kuang… - Medicine, 2019 - journals.lww.com
Background: Due to the resurgence of pertussis, many countries have revised the pertussis
immunization schedules and recommended booster doses of pertussis component vaccine …
immunization schedules and recommended booster doses of pertussis component vaccine …
Comparison of the tolerability of an acellular pertussis-containing vaccine given as the fifth booster dose in differently primed children
JM Kemmeren, SS Timmer, NAT van der Maas… - Vaccine, 2011 - Elsevier
Background In 2005, an acellular pertussis-containing DTP-IPV-Hib vaccine for infants
replaced the whole-cell combination vaccine in the National Immunisation Programme of the …
replaced the whole-cell combination vaccine in the National Immunisation Programme of the …
A comparison of booster immunisation with a combination DTPa-IPV vaccine or DTPa plus IPV in separate injections when co-administered with MMR, at age 4–6 …
H Marshall, T Nolan, D Roberton, P Richmond… - Vaccine, 2006 - Elsevier
This study evaluated GSK's combined DTPa-IPV vaccine (Infanrix™-IPV) given as a fifth
consecutive acellular pertussis booster dose in conjunction with the second dose of MMR …
consecutive acellular pertussis booster dose in conjunction with the second dose of MMR …
[PDF][PDF] Immunogenicity, reactogenicity and safety of a diphtheria-tetanus-acellular pertussis-inactivated polio and Haemophilus influenzae type b combination vaccine …
KB Phua, SH Quak, FS Lim, P Goh… - Annals Academy of …, 2008 - researchgate.net
Introduction: In recent years, acellular pertussis combination vaccines have facilitated
compliance with and coverage of the national immunisation programme in Singapore. This …
compliance with and coverage of the national immunisation programme in Singapore. This …
Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix®) in adults 55 years of age and over: A sub-analysis of four trials
P Van Damme, P McIntyre, E Grimprel, S Kuriyakose… - Vaccine, 2011 - Elsevier
BACKGROUND: Older adults, especially those over 65 years, are at risk of more severe
morbidity from diphtheria, tetanus and pertussis and may transmit pertussis to unvaccinated …
morbidity from diphtheria, tetanus and pertussis and may transmit pertussis to unvaccinated …